Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen binding

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 12, 2005, Pages 2689-2694

  Baronciani, L ^a   Federici, A B ^a   Beretta, M ^a   Cozzi, G ^a   Canciani, M T ^a   Mannucci, P M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Collagen; Expression study; Type 2B; Von Willebrand disease

Indexed keywords

AMINO ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DESMOPRESSIN; GLYCOPROTEIN IB ALPHA; VON WILLEBRAND FACTOR;

ADULT; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

ADULT; ANIMALS; CERCOPITHECUS AETHIOPS; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE III; COS CELLS; FAMILY HEALTH; FEMALE; HETEROZYGOTE; HUMANS; ITALY; MEMBRANE PROTEINS; MUTATION, MISSENSE; PROTEIN BINDING; TRANSDUCTION, GENETIC; VON WILLEBRAND FACTOR;

EID: 29244469439     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01638.x     Document Type: Article

References (17)

1. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
2. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-97.
3. Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980; 302: 1047-51.
4. Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjorin E. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease. N Engl J Med 1983; 309: 816-21.
5. Weiss HJ, Sussman II. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers. Blood 1986; 68: 149-56.
6. Holmberg L, Berntorp E, Donner M, Nilsson IM. von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma. Blood 1986; 68: 668-72.
7. Holmberg L, Dent JA, Schneppenheim R, Budde U, Ware J, Ruggeri ZM. von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure. J Clin Invest 1993; 91: 2169-77.
8. Federici AB, Canciani MT, Forza I, Mannucci PM, Marchese P, Ware J, Ruggeri ZM. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibα for the diagnosis of patients with low von Willebrand factor levels. Haematologica 2004; 89: 77-85.
9. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981; 57: 1140-3.
10. Federici AB, Mazurier C, Berntorp E, Lee CA, Scharrer I, Goudemand J, Lethagen S, Nitu I, Ludwig G, Hilbert L, Mannucci PM. Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood 2004; 103: 2032-8.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
12. Baronciani L, Cozzi G, Canciani MT, Peyvandi F, Srivastava A, Federici AB, Mannucci PM. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis 2003; 30: 264-70.
13. Hilbert L, Gaucher C, De Romeuf C, Horellou MH, Vink T, Mazurier C. Leu 697 → Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease. Blood 1994; 83: 1542-50.
14. Randi AM, Jorieux S, Tuley EA, Mazurier C, Sadler JE. Willebrand factor Arg (578) → Gln: a type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin. J Biol Chem 1992; 267: 21187-92.
15. Lankhof H, Damas C, Schiphorst ME, Ijsseldijk MJW, Bracke M, Sixma JJ, Vink T, Groot PG. Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flow. Blood 1997; 89: 2766-72.
16. Inbal A, Kornbrot N, Harrison P, Randi AM, Sadler JE. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding studies with recombinant von Willebrand factor. Tromb Haemost 1993; 70: 1058-62.
17. Federici AB, Canciani MT, Forza I, Cozzi G. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease. Tromb Haemost 2000; 84: 1127-8.